Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
about
Nanoshell-mediated targeted photothermal therapy of HER2 human breast cancer cells using pulsed and continuous wave lasers: an in vitro study.Evaluation of the intestinal permeability of rosemary (Rosmarinus officinalis L.) extract polyphenols and terpenoids in Caco-2 cell monolayers.Bispecific Antibody Conjugated Manganese-Based Magnetic Engineered Iron Oxide for Imaging of HER2/neu- and EGFR-Expressing TumorsMelittin induces human gastric cancer cell apoptosis via activation of mitochondrial pathwayAntibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cellsBee venom in cancer therapy.Functional liposomes in the cancer-targeted drug delivery.Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan.Lipid-based nanocarriers for breast cancer treatment - comprehensive review.Antibody-targeted biodegradable nanoparticles for cancer therapy.Antibodies as stratagems against cancer.Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells.Quantifying nuclear p65 as a parameter for NF-κB activation: Correlation between ImageStream cytometry, microscopy, and Western blot.A conjugate of the lytic peptide Hecate and gallic acid: structure, activity against cervical cancer, and toxicity.DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer.Plasma membrane aquaporins mediates vesicle stability in broccoli.Therapeutically Induced Changes in HER2, HER3, and EGFR Protein Expression for Treatment Guidance.
P2860
Q35681637-BC38B6AB-0CAF-4DED-9D2F-945ACDB348F4Q36289570-35E41541-D1F1-4BBD-ABE7-59758F84A00CQ36372353-195B64A4-E52F-4490-84C8-BE6AD9ABEE08Q36682603-D16B85B5-55B6-42B1-8FD1-5D95D1FE393BQ36962681-5F244CA6-0D03-48AC-AEF9-4D5197D40432Q37959814-5ADF8186-ACA0-47EC-AB1A-18CA6168BF1EQ38396298-609D0985-A1AB-44DE-B52E-BFC95D7D0F0EQ38401839-AABC9ADD-5C22-4079-B0A2-74E638C5424CQ38597794-0EBA4A08-EC09-497A-8957-BE12E4F7D341Q38665261-60B8C523-C098-4C2B-8A94-F74C374C20C0Q38688747-B50EA9CE-6D74-4DA2-84E2-886C401C9EA4Q38768426-2B9DBA49-6D5C-45EE-AAFA-7F6ED09ED930Q39108086-CD579CE3-327B-4A68-8F6C-2D2A5203120BQ39552773-DACABA5E-AD25-496E-B16D-CBB8C1555136Q41080238-7D7C8672-8B25-4441-B66D-DC63F5FAE6E6Q47170552-6B274815-5DBB-4589-9CAB-3B8C852BA31AQ50053560-3380069D-B4F0-4EBF-9CAB-7FC785ADB8C8Q50854840-C8738C84-BCF2-4F68-866D-4601588173D3
P2860
Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Selective death of human breas ...... h their HER2 expression level.
@en
Selective death of human breas ...... h their HER2 expression level.
@nl
type
label
Selective death of human breas ...... h their HER2 expression level.
@en
Selective death of human breas ...... h their HER2 expression level.
@nl
prefLabel
Selective death of human breas ...... h their HER2 expression level.
@en
Selective death of human breas ...... h their HER2 expression level.
@nl
P50
P1433
P1476
Selective death of human breas ...... th their HER2 expression level
@en
P2093
Alfredo Carrato
María P Menéndez-Gutiérrez
P304
P356
10.1016/J.CANLET.2009.09.010
P407
P577
2009-11-05T00:00:00Z